Preclinical Dermal

GHK-Cu

Copper tripeptide (glycyl-histidyl-lysine copper complex)

Copper peptide studied in dermal remodeling and cosmetics.

Back to technical sheets
Class
Copper tripeptide (glycyl-histidyl-lysine copper complex)
Also known as
Topical cosmetic use; not an approved systemic drug

Mechanism of action

Copper complex with proposed effects on extracellular-matrix remodeling, antioxidant activity and collagen synthesis. Evidence is mostly topical and in vitro.

Evidence

Preclinical

Topical cosmetic use with in-vitro and small dermal clinical studies. It is not an approved systemic drug. Preclinical for systemic uses.

Studied uses

  • Topical skin care / cosmeceuticals

Safety considerations

  • Limited systemic data
  • Possible topical irritation
  • Not approved as a systemic drug

Batch quality data

We publish these figures because they are the ones the program itself teaches you to ask for.

GHK-Cu
Presentation
Polvo liofilizado en vial sellado
50 mg MX$1,200 per vial

Educational reference sheet. It is not a recommendation to use, a clinical indication or a protocol. Many of these compounds are marketed for research use only and are not approved for human use. Always cross-check with the primary literature and the regulation in your country.